Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032
With its low survival rates and limited treatment options, pancreatic cancer remains a significant focus of medical research and development efforts.
- With its low survival rates and limited treatment options, pancreatic cancer remains a significant focus of medical research and development efforts.
- The report said: “This growth is driven by increasing instances of pancreatic cancer and higher investments in pancreatic oncology research.
- In recent years, the pancreatic cancer market has experienced steady growth, largely driven by the increasing prevalence of pancreatic cancer cases globally.
- BioSpace concluded: “Several notable trends are shaping the pancreatic cancer market.